EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The “five-star matrix” for patient-centric drug discovery and development in neuroscience

Axel Pähler, Eoin C O'Connor, Hayley Binch, Sherri Dudal, Luca C Gobbi, Thomas Lübbers, Andrés Olivares-Morales, Rosa María Rodríguez Sarmiento, Uwe Grether, Martin Stahl, Gennaro Pagano, Antonia F Stepan

Neuron · 2025-09 · 113 (18) · 2885-2909

DOI: 10.1016/j.neuron.2025.08.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuron, 2025-09. Verfasst von Axel Pähler und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland. Electronic address: axel.pae…. Hauptthemen laut MEDLINE: Drug Discovery, Neurosciences, Drug Development, Translational Research, Biomedical. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 226 Literaturangaben. Gefördert von: Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progress in understanding human biology has revealed potential therapeutic targets for brain disorders. Yet, the discovery of new neuroscience drugs is often hampered by the lack of precise translation tools and disease models, resulting in high preclinical and clinical failure rates. To improve success, robust translational foundations linking pharmacological targets to disease phenotypes are essential. The "five-star matrix" offers a comprehensive framework for translational drug discovery, consisting of five "dimensions" (biodistribution, target binding/occupancy, proximal effect, biological effect, and disease effect) and five "systems" (biochemical, cellular, ex vivo, preclinical, and clinical). By identifying translatable biomarkers across these dimensions and systems, researchers can test hypotheses from early target assessments to clinical studies. Although linking pathogenic processes to disease-relevant endpoints is challenging, applying the five-star matrix across neuroscience projects fosters collaboration to develop holistic, patient-centric strategies with clear deliverables toward clinical proof of concept. Case studies illustrate the rationale for the five-star matrix in creating a translational continuum from bench to bedside.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryNeurosciencesDrug DevelopmentTranslational Research, BiomedicalBrain DiseasesHumansAnimals

Autor:innen und Institutionen

  • Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland. Electronic address: axel.paehler@roche.com.
  • Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland.
  • Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland. Electronic address: antonia.stepan@roche.com.

Förderung

  • Roche

Zitieren

APA

Pähler, A., O'Connor, E. C., Binch, H., Dudal, S., Gobbi, L. C., Lübbers, T., Olivares-Morales, A., Rodríguez Sarmiento, R. M., Grether, U., Stahl, M., Pagano, G., & Stepan, A. F. (2025). The “five-star matrix” for patient-centric drug discovery and development in neuroscience. Neuron, 113(18), 2885-2909. https://doi.org/10.1016/j.neuron.2025.08.004

Vancouver

Pähler A, O'Connor EC, Binch H, Dudal S, Gobbi LC, Lübbers T, et al. The “five-star matrix” for patient-centric drug discovery and development in neuroscience. Neuron. 2025;113(18):2885-2909. doi:10.1016/j.neuron.2025.08.004

BibTeX
@article{Phler2025,
  author = {Pähler, Axel and O'Connor, Eoin C and Binch, Hayley and Dudal, Sherri and Gobbi, Luca C and Lübbers, Thomas and Olivares-Morales, Andrés and Rodríguez Sarmiento, Rosa María and Grether, Uwe and Stahl, Martin and Pagano, Gennaro and Stepan, Antonia F},
  title = {The “five-star matrix” for patient-centric drug discovery and development in neuroscience},
  journal = {Neuron},
  year = {2025},
  volume = {113},
  number = {18},
  pages = {2885--2909},
  doi = {10.1016/j.neuron.2025.08.004}
}
Kostenlos starten →